Apimeds Pharmaceuticals US, Inc. (APUS) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Apimeds Pharmaceuticals US, Inc. (APUS) closed at USD 4.58 on 2026-10-14, a change of -77.5 % over the past year, with a market capitalization of USD 6.63M.

Apimeds Pharmaceuticals US, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Apimeds Pharmaceuticals US, Inc. key figures

Previous close

USD 4.58 (2026-10-14)

1-year change

-77.5 %

Market cap

USD 6.63M

Enterprise value

n/a

P/E ratio (trailing)

-0.13

P/E ratio (forward)

n/a

EPS (trailing)

-34.24

EPS (forward)

n/a

PEG ratio

n/a

Price to book

6.76

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.01

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Apimeds Pharmaceuticals US, Inc. and compare it with other stocks.